The EU Drugs Action Plan requires member states to work with the EMCDDA to provide reliable and comparable data on five key epidemiological indicators covering: Prevalence and patterns of drug use among the general population (population surveys);
Prevalence and patterns of problem drug use (statistical prevalence/incidence estimates and surveys among drug users);
Prevalence and incidence rates of drug-related infectious diseases (prevalence and incidence rates of HIV, hepatitis B and C in injecting drug users);
Drug-related deaths amongst drug users (general population mortality special registers statistics, and mortality cohort studies among drug users); and
Drug treatment demand (statistics from drug treatment centres on clients starting treatment).
Detailed information on each of the indicators can be found on the relevant pages of the EMCDDA website. The UK Focal Point works in conjunction with leading experts for each of the indicators, who provide valuable data and information about their fields. Workshops are held to discuss and agree what data is available for each indicator in the UK and each year the experts compile a report on the status of implementation of the relevant indicator. The latest reports are available below. The Focal Point also works with the devolved administrations to improve the comparability of data both within the UK and at EU level. Comparability of data presents particular challenges for countries like the UK where established data sources, which do not comply precisely with the European protocols, exist. Devolution of responsibility for a range of policy areas to administrations in Northern Ireland, Scotland and Wales also means that data availability may vary across the UK. The work of the Focal Point concentrates on improving consistency with the EMCDDA protocols and specifications and on improving comparability of data between the four UK administrations, wherever possible. |
